134 Clinical Trials for: SEARCH[STUDY] MK-3475, Page 1 of 7

Hide Studies Not Seeking New Volunteers


A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of MK-3475 in Combination With INCB024360 in Subjects With Selected Cancers (INCB 24360-202 / MK-3475-037 / KEYNOTE-037)

Condition(s): Malignant Solid Tumour; Lymphoma, Large B-Cell, Diffuse; Carcinoma, Non-Small-Cell Lung; Transitional Cell Carcinoma of Digestive Tract; HER-2 Positive Breast Cancer; Carcinoma, Squamous Cell of Head and Neck; Ovarian Neoplasms; Adenocarcinoma of the Endometrium; Renal Cell Carcinoma Last Updated: August 24, 2015Recruiting


Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Urothelial Cancer, Melanoma, and Non-Small Cell Lung Cancer

Condition(s): Head and Neck Squamous Cell Carcinoma; Metastatic Renal Cell Cancer; Recurrent Head and Neck Carcinoma; Recurrent Non-Small Cell Lung Carcinoma; Recurrent Renal Cell Carcinoma; Recurrent Skin Carcinoma; Stage III Renal Cell Cancer; Stage IV Non-Small Cell Lung Cancer; Stage IV Skin Melanoma Last Updated: July 30, 2015Recruiting